Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 16;20(14):3494.
doi: 10.3390/ijms20143494.

Platelets Are Critical Key Players in Sepsis

Affiliations
Review

Platelets Are Critical Key Players in Sepsis

Fanny Vardon-Bounes et al. Int J Mol Sci. .

Abstract

Host defense against infection is based on two crucial mechanisms: the inflammatory response and the activation of coagulation. Platelets are involved in both hemostasis and immune response. These mechanisms work together in a complex and synchronous manner making the contribution of platelets of major importance in sepsis. This is a summary of the pathophysiology of sepsis-induced thrombocytopenia, microvascular consequences, platelet-endothelial cells and platelet-pathogens interactions. The critical role of platelets during sepsis and the therapeutic implications are also reviewed.

Keywords: endothelium; immunothrombosis; platelets; sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Selected examples of pro-inflammatory role of platelets during sepsis: endothelial damage and interactions with pathogens such as pathogens-associated molecular patterns (PAMPs) activate platelets that interact with endothelium, with monocytes and neutrophils, promoting neutrophils extra-cellular Trap (NET)osis, neutrophils transmigration, activation of coagulation through tissue factor release and immunothrombosis. DAMPs: damage associated molecular patterns (microvesicles, free DNA, protease).

References

    1. Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801–810. doi: 10.1001/jama.2016.0287. - DOI - PMC - PubMed
    1. Iskander K.N., Osuchowski M.F., Stearns-Kurosawa D.J., Kurosawa S., Stepien D., Valentine C., Remick D.G. Sepsis: Multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol. Rev. 2013;93:1247–1288. doi: 10.1152/physrev.00037.2012. - DOI - PMC - PubMed
    1. Pfeiler S., Massberg S., Engelmann B. Biological basis and pathological relevance of microvascular thrombosis. Thromb. Res. 2014;133:S35–S37. doi: 10.1016/j.thromres.2014.03.016. - DOI - PubMed
    1. Engelmann B., Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 2012;13:34–45. doi: 10.1038/nri3345. - DOI - PubMed
    1. Hui P., Cook DJ M.E., Lim W., Fraser G.A., Arnold D.M. The Frequency and Clinical Significance of Thrombocytopenia Complicating Critical Illness. Chest. 2011;139:271–278. doi: 10.1378/chest.10-2243. - DOI - PubMed

Substances